CONTENTS:
- Pathways through opiate use and offending: A systematic review. Hayhurst K.P., Pierce M., Hickman M., Seddon T., Dunn G., Keane J., et al., p. 1-13.
- Young people and injection drug use: Is there a need to expand harm reduction services and support? Adamson K., Jackson L., Gahagan J., p. 14-20.
- Injection-site vein loss and soft tissue abscesses associated with black tar heroin injection: A cross-sectional study of two distinct populations in USA. Summers P.J., Struve I.A., Wilkes M.S., Rees V.W., p. 21-27.
- Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective. Apud I., Romaní O., p. 28-36.
- Factors associated with syphilis seroreactivity among polydrug users in Northeast Brazil: A cross-sectional study using Respondent Driven Sampling. Baptista C.J., Dourado I., Brignol S., Andrade T.d.M., Bastos F.I., p. 37-42.
- Maritime transportation of illegal drugs from South America. Atkinson M.P., Kress M., Szechtman R., p. 43-51.
- Creating visual differences: Methamphetamine users perceptions of anti-meth campaigns. Marsh W., Copes H., Linnemann T., p. 52-61.
- Non-medical use of prescription drugs among illicit drug users: A case study on an online drug forum. Rönkä S., Katainen A., p. 62-68.
- Drug use in business bathrooms: An exploratory study of manager encounters in New York City. Wolfson-Stofko B., Bennett A.S., Elliott L., Curtis R., p. 69-77.
- Exploring the social lives of image and performance enhancing drugs: An online ethnography of the Zyzz fandom of recreational bodybuilders. Underwood M., p. 78-85.
- Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). Carrieri P., Vilotitch A., Nordmann S., Lions C., Michel L., Mora M., et al., p. 86-91.
- "We're giving you something so we get something in return": Perspectives on research participation and compensation among people living with HIV who use drugs. Collins A.B., Strike C., Guta A., Baltzer Turje R., McDougall P., Parashar S., et al., p. 92-98.
- Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England. Kesten J.M., Ayres R., Neale J., Clark J., Vickerman P., Hickman M., et al., p. 99-108.
- Rethinking retention in treatment of opioid dependence - The eye of the beholder. Vogel M., Dürsteler K.M., Walter M., Herdener M., Nordt C., p. 109-113.
- Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs. Walley A.Y., Cheng D.M., Quinn E.K., Blokhina E., Gnatienko N., Chaisson C.E., et al., p. 114-120.
- Drug decriminalization and the price of illicit drugs. Félix S., Portugal P., p. 121-129.
- Reasons for missed appointments with a hepatitis C outreach clinic: A qualitative study. Poll R., Allmark P., Tod A.M., p. 130-137.
- Alprazolam in fatal overdose following regulatory rescheduling: A response to Deacon et al. Lloyd B., Dwyer J., Bugeja L., Jamieson A., p. 138-139.
- Transitions at the International Journal of Drug Policy [Editorial]. Rhodes T., p. 141-142.
- My time with the International Journal of Drug Policy [Editorial]. Stimson G.V., p. 143-145.